These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 27636102

  • 1. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
    Velizheva NP, Rechsteiner MP, Wong CE, Zhong Q, Rössle M, Bode B, Moch H, Soltermann A, Wild PJ, Tischler V.
    Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.
    Karnes HE, Duncavage EJ, Bernadt CT.
    Cancer Cytopathol; 2014 Feb; 122(2):104-13. PubMed ID: 24227699
    [Abstract] [Full Text] [Related]

  • 4. Clinical next-generation sequencing in patients with non-small cell lung cancer.
    Hagemann IS, Devarakonda S, Lockwood CM, Spencer DH, Guebert K, Bredemeyer AJ, Al-Kateb H, Nguyen TT, Duncavage EJ, Cottrell CE, Kulkarni S, Nagarajan R, Seibert K, Baggstrom M, Waqar SN, Pfeifer JD, Morgensztern D, Govindan R.
    Cancer; 2015 Feb 15; 121(4):631-9. PubMed ID: 25345567
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.
    Gailey MP, Stence AA, Jensen CS, Ma D.
    Cancer Cytopathol; 2015 Jan 15; 123(1):30-9. PubMed ID: 25186473
    [Abstract] [Full Text] [Related]

  • 7. Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.
    Bonfiglio S, Vanni I, Rossella V, Truini A, Lazarevic D, Dal Bello MG, Alama A, Mora M, Rijavec E, Genova C, Cittaro D, Grossi F, Coco S.
    BMC Cancer; 2016 Aug 30; 16(1):692. PubMed ID: 27578032
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T, Robinson C, Grieu-Iacopetta F, Millward M, Iacopetta B, Spagnolo D, Amanuel B.
    Pathology; 2018 Jun 30; 50(4):389-401. PubMed ID: 29752127
    [Abstract] [Full Text] [Related]

  • 11. Performance of Idylla KRAS assay on extracted DNA and de-stained cytology smears: Can we rescue small sample?
    Wei Q, Eltoum IA, Mackinnon AC, Harada S.
    Ann Diagn Pathol; 2022 Oct 30; 60():152023. PubMed ID: 35961282
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous detection of single-nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA-based next-generation sequencing assay.
    Guseva NV, Jaber O, Stence AA, Sompallae K, Bashir A, Sompallae R, Bossler AD, Jensen CS, Ma D.
    Cancer Cytopathol; 2018 Mar 30; 126(3):158-169. PubMed ID: 29364576
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
    Sie D, Snijders PJ, Meijer GA, Doeleman MW, van Moorsel MI, van Essen HF, Eijk PP, Grünberg K, van Grieken NC, Thunnissen E, Verheul HM, Smit EF, Ylstra B, Heideman DA.
    Cell Oncol (Dordr); 2014 Oct 30; 37(5):353-61. PubMed ID: 25209392
    [Abstract] [Full Text] [Related]

  • 16. Cell block-based RNA next generation sequencing for detection of gene fusions in lung adenocarcinoma: An institutional experience.
    Wei S, Talarchek JN, Huang M, Gong Y, Du F, Ehya H, Flieder DB, Patchefsky AS, Wasik MA, Pei J.
    Cytopathology; 2023 Jan 30; 34(1):28-34. PubMed ID: 36062384
    [Abstract] [Full Text] [Related]

  • 17. Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples.
    Offerman S, Prinsen CF, Knol A, Methorst N, Kamphorst J, Niemantsverdriet M.
    Diagn Pathol; 2021 Aug 03; 16(1):70. PubMed ID: 34344387
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW, Gadellaa-van Hooijdonk CG, Barendregt-Smouter FA, Koudijs MJ, Nijman I, Hinrichs JW, Cuppen E, van Lieshout S, Loberg RD, de Jonge M, Voest EE, de Weger RA, Steeghs N, Langenberg MH, Sleijfer S, Willems SM, Lolkema MP.
    PLoS One; 2016 Aug 03; 11(2):e0149405. PubMed ID: 26919633
    [Abstract] [Full Text] [Related]

  • 20. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
    Han JY, Kim SH, Lee YS, Lee SY, Hwang JA, Kim JY, Yoon SJ, Lee GK.
    Lung Cancer; 2014 Aug 03; 85(2):161-7. PubMed ID: 24857785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.